217 related articles for article (PubMed ID: 6514012)
1. Stereoselective inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by 4-dimethylamino-2,alpha-dimethylphenethylamine (FLA 336).
Fowler CJ; Eriksson M; Thorell G; Magnusson O
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):279-84. PubMed ID: 6514012
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of monoamine oxidase and semicarbazide-sensitive amine oxidase by mexiletine and related compounds.
Eriksson M; Fowler CJ
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):273-8. PubMed ID: 6514011
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of monoamine oxidase A-form and semicarbazide-sensitive amine oxidase by selective and reversible monoamine oxidase-A inhibitors, amiflamine and FLA 788(+).
Morikawa F; Ueda T; Arai Y; Kinemuchi H
Pharmacology; 1986; 32(1):38-45. PubMed ID: 3945672
[TBL] [Abstract][Full Text] [Related]
4. Effect of pyridoxamine on semicarbazide-sensitive amine oxidase activity of rabbit lung and heart.
Buffoni F; Banchelli G; Bertocci B; Raimondi L
J Pharm Pharmacol; 1989 Jul; 41(7):469-73. PubMed ID: 2570852
[TBL] [Abstract][Full Text] [Related]
5. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. II. Inhibition by alpha-methylated substrate-analogue monoamines, alpha-methyltryptamine, alpha-methylbenzylamine and two enantiomers of alpha-methylbenzylamine.
Arai Y; Toyoshima Y; Kinemuchi H
Jpn J Pharmacol; 1986 Jun; 41(2):191-7. PubMed ID: 3747266
[TBL] [Abstract][Full Text] [Related]
6. Effects of acute and repeated administration of amiflamine on monoamine oxidase inhibition in the rat.
Ask AL; Fagervall I; Jonze M; Kelder D; Nygren R; Ross SB
Biochem Pharmacol; 1984 Sep; 33(18):2839-47. PubMed ID: 6477643
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition by amiflamine of monoamine oxidase type A in rat brain, liver and duodenum.
Ask AL
Naunyn Schmiedebergs Arch Pharmacol; 1984 Aug; 327(1):56-63. PubMed ID: 6493351
[TBL] [Abstract][Full Text] [Related]
8. Studies of monoamine oxidase and semicarbazide-sensitive amine oxidase. I. Inhibition by a selective monoamine oxidase-B inhibitor, MD 780236.
Kinemuchi H; Morikawa F; Ueda T; Arai Y
Jpn J Pharmacol; 1986 Jun; 41(2):183-9. PubMed ID: 3747265
[TBL] [Abstract][Full Text] [Related]
9. The ex vivo effects of procarbazine and methylhydrazine on some rat amine oxidase activities.
Holt A; Callingham BA
J Neural Transm Suppl; 1994; 41():439-43. PubMed ID: 7931263
[TBL] [Abstract][Full Text] [Related]
10. (+)-4-Dimethylamino-2,alpha-dimethylphenethylamine (FLA 336(+)), a selective inhibitor of the A form of monoamine oxidase in the rat brain.
Ask AL; Högberg K; Schmidt L; Kiessling H; Ross SB
Biochem Pharmacol; 1982 Apr; 31(7):1401-6. PubMed ID: 7092929
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase and semicarbazide-sensitive amine oxidase in spontaneously hypertensive and in normotensive control rats.
Guffroy C; Strolin Benedetti M
Life Sci; 1984 Feb; 34(6):535-45. PubMed ID: 6694535
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of rat aorta semicarbazide-sensitive amine oxidase by 2-phenyl-3-haloallylamines and related compounds.
Lyles GA; Marshall CM; McDonald IA; Bey P; Palfreyman MG
Biochem Pharmacol; 1987 Sep; 36(17):2847-53. PubMed ID: 3632710
[TBL] [Abstract][Full Text] [Related]
13. Vascular smooth muscle cells: a major source of the semicarbazide-sensitive amine oxidase of the rat aorta.
Lyles GA; Singh I
J Pharm Pharmacol; 1985 Sep; 37(9):637-43. PubMed ID: 2867184
[TBL] [Abstract][Full Text] [Related]
14. Limitation of adipose tissue enlargement in rats chronically treated with semicarbazide-sensitive amine oxidase and monoamine oxidase inhibitors.
Carpéné C; Abello V; Iffiú-Soltész Z; Mercier N; Fève B; Valet P
Pharmacol Res; 2008 Jun; 57(6):426-34. PubMed ID: 18539478
[TBL] [Abstract][Full Text] [Related]
15. Further studies on the ex-vivo effects of procarbazine and monomethylhydrazine on rat semicarbazide-sensitive amine oxidase and monoamine oxidase activities.
Holt A; Callingham BA
J Pharm Pharmacol; 1995 Oct; 47(10):837-45. PubMed ID: 8583353
[TBL] [Abstract][Full Text] [Related]
16. Effects in-vitro of procarbazine metabolites on some amine oxidase activities in the rat.
Holt A; Sharman DF; Callingham BA
J Pharm Pharmacol; 1992 Jun; 44(6):494-9. PubMed ID: 1359074
[TBL] [Abstract][Full Text] [Related]
17. Evidence of semicarbazide-sensitive amine oxidase activity in guinea pig tissues.
Puliti M; Cambi S; Buffoni F
Comp Biochem Physiol B Biochem Mol Biol; 1996 Oct; 115(2):159-65. PubMed ID: 8938996
[TBL] [Abstract][Full Text] [Related]
18. Reduction of fat deposition by combined inhibition of monoamine oxidases and semicarbazide-sensitive amine oxidases in obese Zucker rats.
Carpéné C; Iffiú-Soltesz Z; Bour S; Prévot D; Valet P
Pharmacol Res; 2007 Dec; 56(6):522-30. PubMed ID: 17977742
[TBL] [Abstract][Full Text] [Related]
19. The deamination of n-pentylamine by monoamine oxidase and a semicarbazide-sensitive amine oxidase of rat heart.
Guffroy C; Fowler CJ; Strolin Benedetti M
J Pharm Pharmacol; 1983 Jul; 35(7):416-20. PubMed ID: 6136581
[TBL] [Abstract][Full Text] [Related]
20. Deamination of aliphatic amines by type B monoamine oxidase and semicarbazide-sensitive amine oxidase; pharmacological implications.
Yu PH; Davis BA; Boulton AA; Zuo DM
J Neural Transm Suppl; 1994; 41():397-406. PubMed ID: 7931256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
